

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.09544672 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.45849747 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 4.42342235 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.42342235 |
| 5 | DNA deamination (GO:0045006) | 4.31577114 |
| 6 | proteasome assembly (GO:0043248) | 4.21165920 |
| 7 | ribosomal small subunit biogenesis (GO:0042274) | 4.19520363 |
| 8 | protein complex biogenesis (GO:0070271) | 4.07194360 |
| 9 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.03286140 |
| 10 | viral transcription (GO:0019083) | 4.02680666 |
| 11 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.94358955 |
| 12 | cotranslational protein targeting to membrane (GO:0006613) | 3.94019650 |
| 13 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.89298554 |
| 14 | NADH dehydrogenase complex assembly (GO:0010257) | 3.89298554 |
| 15 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.89298554 |
| 16 | protein targeting to ER (GO:0045047) | 3.86626686 |
| 17 | translational termination (GO:0006415) | 3.85805151 |
| 18 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.83924605 |
| 19 | respiratory chain complex IV assembly (GO:0008535) | 3.78060652 |
| 20 | protein localization to endoplasmic reticulum (GO:0070972) | 3.68880014 |
| 21 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.67473569 |
| 22 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.65146022 |
| 23 | protein maturation by protein folding (GO:0022417) | 3.63738510 |
| 24 | cytochrome complex assembly (GO:0017004) | 3.62593128 |
| 25 | cellular response to zinc ion (GO:0071294) | 3.62271117 |
| 26 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.61317255 |
| 27 | chaperone-mediated protein transport (GO:0072321) | 3.55764141 |
| 28 | termination of RNA polymerase III transcription (GO:0006386) | 3.47830412 |
| 29 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.47830412 |
| 30 | respiratory electron transport chain (GO:0022904) | 3.43206265 |
| 31 | base-excision repair, AP site formation (GO:0006285) | 3.39241191 |
| 32 | GTP biosynthetic process (GO:0006183) | 3.35496290 |
| 33 | electron transport chain (GO:0022900) | 3.35467558 |
| 34 | signal peptide processing (GO:0006465) | 3.35349275 |
| 35 | maturation of SSU-rRNA (GO:0030490) | 3.32020953 |
| 36 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.31911324 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.29889377 |
| 38 | neutrophil activation involved in immune response (GO:0002283) | 3.29005500 |
| 39 | translational elongation (GO:0006414) | 3.26915798 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.23361129 |
| 41 | response to peptidoglycan (GO:0032494) | 3.22011789 |
| 42 | deoxyribonucleotide catabolic process (GO:0009264) | 3.21431986 |
| 43 | viral life cycle (GO:0019058) | 3.15890398 |
| 44 | ribosomal large subunit biogenesis (GO:0042273) | 3.15148041 |
| 45 | deoxyribose phosphate catabolic process (GO:0046386) | 3.13319622 |
| 46 | purine nucleotide salvage (GO:0032261) | 3.11596869 |
| 47 | mannosylation (GO:0097502) | 3.11306920 |
| 48 | cellular protein complex disassembly (GO:0043624) | 3.08828790 |
| 49 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.08175590 |
| 50 | protein neddylation (GO:0045116) | 3.06923245 |
| 51 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.05592840 |
| 52 | positive regulation of prostaglandin secretion (GO:0032308) | 3.04642037 |
| 53 | translation (GO:0006412) | 2.99586332 |
| 54 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.97812531 |
| 55 | regulation of autophagic vacuole assembly (GO:2000785) | 2.96325817 |
| 56 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.95779846 |
| 57 | regulation of mitochondrial translation (GO:0070129) | 2.95380515 |
| 58 | sequestering of actin monomers (GO:0042989) | 2.91449926 |
| 59 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.90356691 |
| 60 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.90350584 |
| 61 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.90350584 |
| 62 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.89857014 |
| 63 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.89857014 |
| 64 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.89857014 |
| 65 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.88994651 |
| 66 | GPI anchor biosynthetic process (GO:0006506) | 2.87462750 |
| 67 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.85885253 |
| 68 | regulation of B cell apoptotic process (GO:0002902) | 2.85822644 |
| 69 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.85707357 |
| 70 | rRNA modification (GO:0000154) | 2.83962158 |
| 71 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.83614836 |
| 72 | negative regulation of ligase activity (GO:0051352) | 2.83614836 |
| 73 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.82635570 |
| 74 | 7-methylguanosine mRNA capping (GO:0006370) | 2.82278575 |
| 75 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.81220586 |
| 76 | protein targeting to mitochondrion (GO:0006626) | 2.79790018 |
| 77 | immunoglobulin mediated immune response (GO:0016064) | 2.79461198 |
| 78 | respiratory burst (GO:0045730) | 2.78400594 |
| 79 | RNA capping (GO:0036260) | 2.78343875 |
| 80 | 7-methylguanosine RNA capping (GO:0009452) | 2.78343875 |
| 81 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.77486178 |
| 82 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.77486178 |
| 83 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.77429044 |
| 84 | pentose metabolic process (GO:0019321) | 2.74727426 |
| 85 | negative regulation of B cell apoptotic process (GO:0002903) | 2.73943859 |
| 86 | cellular response to interferon-beta (GO:0035458) | 2.73764796 |
| 87 | UTP biosynthetic process (GO:0006228) | 2.73178383 |
| 88 | translational initiation (GO:0006413) | 2.72593796 |
| 89 | nucleotide salvage (GO:0043173) | 2.71853513 |
| 90 | mast cell activation (GO:0045576) | 2.71778361 |
| 91 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.70353746 |
| 92 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.68980566 |
| 93 | mature B cell differentiation involved in immune response (GO:0002313) | 2.67961041 |
| 94 | platelet dense granule organization (GO:0060155) | 2.67363767 |
| 95 | CTP metabolic process (GO:0046036) | 2.66952902 |
| 96 | CTP biosynthetic process (GO:0006241) | 2.66952902 |
| 97 | protein localization to mitochondrion (GO:0070585) | 2.64352336 |
| 98 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.62112987 |
| 99 | iron-sulfur cluster assembly (GO:0016226) | 2.61543580 |
| 100 | metallo-sulfur cluster assembly (GO:0031163) | 2.61543580 |
| 101 | peptidyl-histidine modification (GO:0018202) | 2.61214204 |
| 102 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.59486604 |
| 103 | nucleoside salvage (GO:0043174) | 2.58125061 |
| 104 | regulation of vacuole organization (GO:0044088) | 2.57272151 |
| 105 | establishment of protein localization to mitochondrion (GO:0072655) | 2.56789352 |
| 106 | pseudouridine synthesis (GO:0001522) | 2.55800847 |
| 107 | pyrimidine nucleoside salvage (GO:0043097) | 2.55455687 |
| 108 | pyrimidine-containing compound salvage (GO:0008655) | 2.55455687 |
| 109 | protein complex disassembly (GO:0043241) | 2.55374939 |
| 110 | heme biosynthetic process (GO:0006783) | 2.54708274 |
| 111 | cellular component biogenesis (GO:0044085) | 2.54596706 |
| 112 | ubiquinone biosynthetic process (GO:0006744) | 2.53781831 |
| 113 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.53518641 |
| 114 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.52515002 |
| 115 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.50912693 |
| 116 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.50912693 |
| 117 | response to interferon-beta (GO:0035456) | 2.50040154 |
| 118 | protein targeting to membrane (GO:0006612) | 2.49913759 |
| 119 | cellular response to cadmium ion (GO:0071276) | 2.49849523 |
| 120 | hydrogen ion transmembrane transport (GO:1902600) | 2.48960651 |
| 121 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.48912084 |
| 122 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.47069667 |
| 123 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.45937206 |
| 124 | deoxyribose phosphate metabolic process (GO:0019692) | 2.45761848 |
| 125 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.45338501 |
| 126 | regulation of prostaglandin secretion (GO:0032306) | 2.45005401 |
| 127 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.44605080 |
| 128 | macromolecular complex disassembly (GO:0032984) | 2.44552605 |
| 129 | GDP-mannose metabolic process (GO:0019673) | 2.44416285 |
| 130 | cellular metabolic compound salvage (GO:0043094) | 2.43875591 |
| 131 | amyloid precursor protein catabolic process (GO:0042987) | 2.41818507 |
| 132 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.41122079 |
| 133 | oxidative phosphorylation (GO:0006119) | 2.40756301 |
| 134 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.39785795 |
| 135 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.38151373 |
| 136 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.37679806 |
| 137 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.36915087 |
| 138 | GMP metabolic process (GO:0046037) | 2.36101526 |
| 139 | regulation of cellular amine metabolic process (GO:0033238) | 2.34908747 |
| 140 | positive regulation of ligase activity (GO:0051351) | 2.34741766 |
| 141 | GPI anchor metabolic process (GO:0006505) | 2.34544386 |
| 142 | viral mRNA export from host cell nucleus (GO:0046784) | 2.33857454 |
| 143 | deoxyribonucleotide metabolic process (GO:0009262) | 2.33753825 |
| 144 | proton transport (GO:0015992) | 2.31210560 |
| 145 | anterograde synaptic vesicle transport (GO:0048490) | 2.30430740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.78103821 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.64984257 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.05412689 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.93423077 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.52637953 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.52391971 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.51481702 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.31045635 |
| 9 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.04618042 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.95900364 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.93468579 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.65312549 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.64271669 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.63574260 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.57052265 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.42844791 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.38959676 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.36120530 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.34994563 |
| 20 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.30093800 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27693187 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.26170128 |
| 23 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.22651290 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.21254132 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.20651533 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.18941396 |
| 27 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.15919436 |
| 28 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.11676236 |
| 29 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.11483200 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.07971087 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.07656717 |
| 32 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.01687021 |
| 33 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.01565055 |
| 34 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.95735669 |
| 35 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.91779280 |
| 36 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.90306835 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.84582773 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.83778318 |
| 39 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.83548816 |
| 40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.80687051 |
| 41 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.79470206 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73325451 |
| 43 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72414173 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72346376 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69732965 |
| 46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.65803997 |
| 47 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.62556384 |
| 48 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.62253445 |
| 49 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.60818656 |
| 50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.58560953 |
| 51 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.58403173 |
| 52 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.55075075 |
| 53 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.47952708 |
| 54 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.47608068 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47030406 |
| 56 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.44718659 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42267464 |
| 58 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.42061791 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39663843 |
| 60 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39095575 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.38314356 |
| 62 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.35406634 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35366857 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33501410 |
| 65 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.32093568 |
| 66 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.31905257 |
| 67 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.30402631 |
| 68 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27858851 |
| 69 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.25146599 |
| 70 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.23590955 |
| 71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22469813 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21923489 |
| 73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21482075 |
| 74 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19589178 |
| 75 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.17546137 |
| 76 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13853535 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 1.12561294 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10333055 |
| 79 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09750893 |
| 80 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09570311 |
| 81 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.08678438 |
| 82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06976215 |
| 83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06636775 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.05828903 |
| 85 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.04969820 |
| 86 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04164173 |
| 87 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03900112 |
| 88 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.02503134 |
| 89 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02390212 |
| 90 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.01773652 |
| 91 | P300_27268052_Chip-Seq_Bcells_Human | 1.01325962 |
| 92 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00995476 |
| 93 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00887848 |
| 94 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.00487024 |
| 95 | VDR_22108803_ChIP-Seq_LS180_Human | 1.00220577 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00210523 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99731923 |
| 98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99519653 |
| 99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99390794 |
| 100 | MYB_26560356_Chip-Seq_TH2_Human | 0.99084278 |
| 101 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98310549 |
| 102 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.97678219 |
| 103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96194323 |
| 104 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96075920 |
| 105 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.93506351 |
| 106 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93368797 |
| 107 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.90847734 |
| 108 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90690198 |
| 109 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89387814 |
| 110 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.89306621 |
| 111 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87988727 |
| 112 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.86056959 |
| 113 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.85467855 |
| 114 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.85262072 |
| 115 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.84506205 |
| 116 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.82194323 |
| 117 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.81463303 |
| 118 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81444365 |
| 119 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.80571376 |
| 120 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80459400 |
| 121 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79274375 |
| 122 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.78217756 |
| 123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76514309 |
| 124 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.75222034 |
| 125 | EWS_26573619_Chip-Seq_HEK293_Human | 0.74551534 |
| 126 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.73484857 |
| 127 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.73381674 |
| 128 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.73109226 |
| 129 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72987207 |
| 130 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.72127566 |
| 131 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69943001 |
| 132 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.69334406 |
| 133 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.69066531 |
| 134 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.67963168 |
| 135 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.67539416 |
| 136 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.67392271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.33871552 |
| 2 | MP0009379_abnormal_foot_pigmentation | 3.10527197 |
| 3 | MP0009840_abnormal_foam_cell | 3.00866990 |
| 4 | MP0001986_abnormal_taste_sensitivity | 2.95135042 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.81850703 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.71233776 |
| 7 | MP0003136_yellow_coat_color | 2.36532984 |
| 8 | MP0001188_hyperpigmentation | 2.30142165 |
| 9 | MP0009785_altered_susceptibility_to | 2.24389530 |
| 10 | MP0005671_abnormal_response_to | 2.20837168 |
| 11 | MP0003880_abnormal_central_pattern | 2.19248965 |
| 12 | MP0000015_abnormal_ear_pigmentation | 2.14279887 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.13093656 |
| 14 | MP0002132_abnormal_respiratory_system | 2.10208121 |
| 15 | MP0000372_irregular_coat_pigmentation | 2.06967654 |
| 16 | MP0001529_abnormal_vocalization | 2.06579593 |
| 17 | MP0005174_abnormal_tail_pigmentation | 2.05994424 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.01116372 |
| 19 | MP0005075_abnormal_melanosome_morpholog | 1.97029920 |
| 20 | MP0001905_abnormal_dopamine_level | 1.93645169 |
| 21 | MP0005451_abnormal_body_composition | 1.92235765 |
| 22 | MP0002638_abnormal_pupillary_reflex | 1.85751026 |
| 23 | MP0005025_abnormal_response_to | 1.80529475 |
| 24 | MP0005409_darkened_coat_color | 1.78263908 |
| 25 | MP0005171_absent_coat_pigmentation | 1.76781092 |
| 26 | MP0003724_increased_susceptibility_to | 1.75050226 |
| 27 | MP0002254_reproductive_system_inflammat | 1.74910392 |
| 28 | MP0003075_altered_response_to | 1.74703914 |
| 29 | MP0000343_altered_response_to | 1.74631889 |
| 30 | MP0003195_calcinosis | 1.64713041 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.64511989 |
| 32 | MP0002723_abnormal_immune_serum | 1.61837384 |
| 33 | MP0002419_abnormal_innate_immunity | 1.61647715 |
| 34 | MP0008469_abnormal_protein_level | 1.60558446 |
| 35 | MP0006292_abnormal_olfactory_placode | 1.59571425 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.56779731 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.56689690 |
| 38 | MP0001819_abnormal_immune_cell | 1.56096477 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.55949707 |
| 40 | MP0002277_abnormal_respiratory_mucosa | 1.55343185 |
| 41 | MP0002139_abnormal_hepatobiliary_system | 1.55131030 |
| 42 | MP0006035_abnormal_mitochondrial_morpho | 1.54486671 |
| 43 | MP0009764_decreased_sensitivity_to | 1.54319144 |
| 44 | MP0000490_abnormal_crypts_of | 1.54314848 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.53730205 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.49983422 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.48337872 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.47285750 |
| 49 | MP0002095_abnormal_skin_pigmentation | 1.45715627 |
| 50 | MP0002736_abnormal_nociception_after | 1.44457978 |
| 51 | MP0003786_premature_aging | 1.44289562 |
| 52 | MP0004381_abnormal_hair_follicle | 1.44050959 |
| 53 | MP0000920_abnormal_myelination | 1.40983830 |
| 54 | MP0001800_abnormal_humoral_immune | 1.40939085 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.40336617 |
| 56 | MP0002735_abnormal_chemical_nociception | 1.39528631 |
| 57 | MP0008260_abnormal_autophagy | 1.39437682 |
| 58 | MP0001764_abnormal_homeostasis | 1.39171786 |
| 59 | MP0008058_abnormal_DNA_repair | 1.37586919 |
| 60 | MP0002163_abnormal_gland_morphology | 1.36963293 |
| 61 | MP0004142_abnormal_muscle_tone | 1.33861727 |
| 62 | MP0002405_respiratory_system_inflammati | 1.33008212 |
| 63 | MP0001968_abnormal_touch/_nociception | 1.31370959 |
| 64 | MP0005387_immune_system_phenotype | 1.30047686 |
| 65 | MP0001790_abnormal_immune_system | 1.30047686 |
| 66 | MP0006082_CNS_inflammation | 1.29290343 |
| 67 | MP0003436_decreased_susceptibility_to | 1.29178125 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.28885446 |
| 69 | MP0003763_abnormal_thymus_physiology | 1.27891258 |
| 70 | MP0006276_abnormal_autonomic_nervous | 1.25727351 |
| 71 | MP0001984_abnormal_olfaction | 1.22218055 |
| 72 | MP0000716_abnormal_immune_system | 1.20461315 |
| 73 | MP0003303_peritoneal_inflammation | 1.20329868 |
| 74 | MP0002398_abnormal_bone_marrow | 1.19450112 |
| 75 | MP0006054_spinal_hemorrhage | 1.18155119 |
| 76 | MP0003186_abnormal_redox_activity | 1.17042816 |
| 77 | MP0005166_decreased_susceptibility_to | 1.16707181 |
| 78 | MP0005310_abnormal_salivary_gland | 1.14165606 |
| 79 | MP0004510_myositis | 1.13447861 |
| 80 | MP0003693_abnormal_embryo_hatching | 1.12626780 |
| 81 | MP0004742_abnormal_vestibular_system | 1.12497452 |
| 82 | MP0004947_skin_inflammation | 1.11782337 |
| 83 | MP0000358_abnormal_cell_content/ | 1.10925187 |
| 84 | MP0001970_abnormal_pain_threshold | 1.10773334 |
| 85 | MP0005410_abnormal_fertilization | 1.10184658 |
| 86 | MP0005379_endocrine/exocrine_gland_phen | 1.08026396 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 1.07298628 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 1.06650732 |
| 89 | MP0002272_abnormal_nervous_system | 1.05344991 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 1.05230333 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 1.02861511 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 1.02503019 |
| 93 | MP0001545_abnormal_hematopoietic_system | 1.02503019 |
| 94 | MP0005165_increased_susceptibility_to | 1.02167562 |
| 95 | MP0010155_abnormal_intestine_physiology | 1.01510899 |
| 96 | MP0002429_abnormal_blood_cell | 1.01439082 |
| 97 | MP0005365_abnormal_bile_salt | 1.00931898 |
| 98 | MP0008932_abnormal_embryonic_tissue | 1.00874971 |
| 99 | MP0000858_altered_metastatic_potential | 1.00195838 |
| 100 | MP0005360_urolithiasis | 1.00195263 |
| 101 | MP0002693_abnormal_pancreas_physiology | 0.99939839 |
| 102 | MP0005464_abnormal_platelet_physiology | 0.99652684 |
| 103 | MP0005332_abnormal_amino_acid | 0.98972391 |
| 104 | MP0000681_abnormal_thyroid_gland | 0.98866521 |
| 105 | MP0008004_abnormal_stomach_pH | 0.96687390 |
| 106 | MP0000685_abnormal_immune_system | 0.96176007 |
| 107 | MP0004147_increased_porphyrin_level | 0.96112776 |
| 108 | MP0002722_abnormal_immune_system | 0.95606568 |
| 109 | MP0003866_abnormal_defecation | 0.95545263 |
| 110 | MP0010094_abnormal_chromosome_stability | 0.92393873 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.92020760 |
| 112 | MP0000689_abnormal_spleen_morphology | 0.91563907 |
| 113 | MP0005646_abnormal_pituitary_gland | 0.91266142 |
| 114 | MP0002751_abnormal_autonomic_nervous | 0.88398786 |
| 115 | MP0009643_abnormal_urine_homeostasis | 0.87409741 |
| 116 | MP0005423_abnormal_somatic_nervous | 0.87375514 |
| 117 | MP0005330_cardiomyopathy | 0.87318811 |
| 118 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86764503 |
| 119 | MP0002938_white_spotting | 0.86454857 |
| 120 | MP0009278_abnormal_bone_marrow | 0.85561964 |
| 121 | MP0001485_abnormal_pinna_reflex | 0.84213256 |
| 122 | MP0009763_increased_sensitivity_to | 0.83321513 |
| 123 | MP0002733_abnormal_thermal_nociception | 0.83173657 |
| 124 | MP0000678_abnormal_parathyroid_gland | 0.82895318 |
| 125 | MP0002102_abnormal_ear_morphology | 0.82623520 |
| 126 | MP0001853_heart_inflammation | 0.81499618 |
| 127 | MP0001963_abnormal_hearing_physiology | 0.81191529 |
| 128 | MP0008789_abnormal_olfactory_epithelium | 0.80899777 |
| 129 | MP0001542_abnormal_bone_strength | 0.80784292 |
| 130 | MP0001663_abnormal_digestive_system | 0.80695536 |
| 131 | MP0002166_altered_tumor_susceptibility | 0.80060516 |
| 132 | MP0002064_seizures | 0.79304991 |
| 133 | MP0002019_abnormal_tumor_incidence | 0.77473354 |
| 134 | MP0008873_increased_physiological_sensi | 0.77441560 |
| 135 | MP0008007_abnormal_cellular_replicative | 0.77436334 |
| 136 | MP0002734_abnormal_mechanical_nocicepti | 0.77079707 |
| 137 | MP0003172_abnormal_lysosome_physiology | 0.76512142 |
| 138 | MP0003448_altered_tumor_morphology | 0.74999158 |
| 139 | MP0006036_abnormal_mitochondrial_physio | 0.74220655 |
| 140 | MP0005636_abnormal_mineral_homeostasis | 0.73321131 |
| 141 | MP0001486_abnormal_startle_reflex | 0.72360493 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.72219779 |
| 143 | MP0000703_abnormal_thymus_morphology | 0.71486168 |
| 144 | MP0001919_abnormal_reproductive_system | 0.70958256 |
| 145 | MP0009046_muscle_twitch | 0.70834041 |
| 146 | MP0002572_abnormal_emotion/affect_behav | 0.70727977 |
| 147 | MP0003718_maternal_effect | 0.70691868 |
| 148 | MP0002006_tumorigenesis | 0.69023198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mitochondrial inheritance (HP:0001427) | 4.33324862 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.31709768 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.19602783 |
| 4 | Increased hepatocellular lipid droplets (HP:0006565) | 4.06841110 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 4.05451782 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.84213456 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.80929549 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.80929549 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.80929549 |
| 10 | Hepatocellular necrosis (HP:0001404) | 3.71032190 |
| 11 | 3-Methylglutaconic aciduria (HP:0003535) | 3.65530666 |
| 12 | Increased CSF lactate (HP:0002490) | 3.62377806 |
| 13 | Renal Fanconi syndrome (HP:0001994) | 3.61982087 |
| 14 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.56334482 |
| 15 | Progressive macrocephaly (HP:0004481) | 3.46755771 |
| 16 | Type I transferrin isoform profile (HP:0003642) | 3.43980336 |
| 17 | Lipid accumulation in hepatocytes (HP:0006561) | 3.41084097 |
| 18 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.36717716 |
| 19 | Reticulocytopenia (HP:0001896) | 3.14571721 |
| 20 | Exertional dyspnea (HP:0002875) | 3.11159466 |
| 21 | Acute encephalopathy (HP:0006846) | 3.07825241 |
| 22 | Recurrent abscess formation (HP:0002722) | 2.99442745 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.97446926 |
| 24 | Hepatic necrosis (HP:0002605) | 2.97234296 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 2.95569679 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.90249657 |
| 27 | Petechiae (HP:0000967) | 2.89154805 |
| 28 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.77882053 |
| 29 | Loss of speech (HP:0002371) | 2.77801948 |
| 30 | Abnormal hair whorl (HP:0010721) | 2.75915570 |
| 31 | Hypothermia (HP:0002045) | 2.73997678 |
| 32 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.69632631 |
| 33 | Patchy hypopigmentation of hair (HP:0011365) | 2.69212820 |
| 34 | Generalized aminoaciduria (HP:0002909) | 2.65445162 |
| 35 | Cerebral hypomyelination (HP:0006808) | 2.60835117 |
| 36 | Increased intramyocellular lipid droplets (HP:0012240) | 2.60649566 |
| 37 | Increased serum lactate (HP:0002151) | 2.59938066 |
| 38 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.58022333 |
| 39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.58022333 |
| 40 | Pallor (HP:0000980) | 2.57021650 |
| 41 | Cerebral edema (HP:0002181) | 2.54967526 |
| 42 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.50702274 |
| 43 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.50702274 |
| 44 | Abnormal protein glycosylation (HP:0012346) | 2.50702274 |
| 45 | Abnormal glycosylation (HP:0012345) | 2.50702274 |
| 46 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.50573216 |
| 47 | White forelock (HP:0002211) | 2.50269069 |
| 48 | Respiratory difficulties (HP:0002880) | 2.48357203 |
| 49 | Ragged-red muscle fibers (HP:0003200) | 2.48251669 |
| 50 | Exercise intolerance (HP:0003546) | 2.44581884 |
| 51 | Microvesicular hepatic steatosis (HP:0001414) | 2.43925018 |
| 52 | Abnormality of renal resorption (HP:0011038) | 2.43617819 |
| 53 | Increased serum ferritin (HP:0003281) | 2.42176522 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.40269607 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.40269607 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.37516272 |
| 57 | Optic disc pallor (HP:0000543) | 2.34962024 |
| 58 | Leukodystrophy (HP:0002415) | 2.34840236 |
| 59 | Stomatitis (HP:0010280) | 2.34218826 |
| 60 | Macrocytic anemia (HP:0001972) | 2.32532510 |
| 61 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.31723346 |
| 62 | Respiratory failure (HP:0002878) | 2.30281981 |
| 63 | Abnormality of T cell physiology (HP:0011840) | 2.28716396 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.25485416 |
| 65 | Obstructive lung disease (HP:0006536) | 2.25367711 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 2.25367711 |
| 67 | Recurrent bacterial skin infections (HP:0005406) | 2.24246340 |
| 68 | Aplastic anemia (HP:0001915) | 2.23983280 |
| 69 | Progressive neurologic deterioration (HP:0002344) | 2.22430199 |
| 70 | CNS demyelination (HP:0007305) | 2.18910750 |
| 71 | Lactic acidosis (HP:0003128) | 2.17156377 |
| 72 | Reduced antithrombin III activity (HP:0001976) | 2.12777937 |
| 73 | Myositis (HP:0100614) | 2.12194125 |
| 74 | Medial flaring of the eyebrow (HP:0010747) | 2.10736062 |
| 75 | Emotional lability (HP:0000712) | 2.09369273 |
| 76 | Poor head control (HP:0002421) | 2.08264415 |
| 77 | Testicular atrophy (HP:0000029) | 2.07098022 |
| 78 | Nausea (HP:0002018) | 2.06505818 |
| 79 | Lethargy (HP:0001254) | 2.06417651 |
| 80 | Abnormality of lateral ventricle (HP:0030047) | 2.04694707 |
| 81 | Panhypogammaglobulinemia (HP:0003139) | 2.02124250 |
| 82 | Increased muscle lipid content (HP:0009058) | 2.00562437 |
| 83 | Parakeratosis (HP:0001036) | 1.99945334 |
| 84 | Mutism (HP:0002300) | 1.99943519 |
| 85 | Autoimmune hemolytic anemia (HP:0001890) | 1.98081328 |
| 86 | Delusions (HP:0000746) | 1.97879229 |
| 87 | Vacuolated lymphocytes (HP:0001922) | 1.97820035 |
| 88 | Microretrognathia (HP:0000308) | 1.97280581 |
| 89 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.95790669 |
| 90 | Recurrent cutaneous fungal infections (HP:0011370) | 1.95790669 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 1.95664196 |
| 92 | Nephrogenic diabetes insipidus (HP:0009806) | 1.95228410 |
| 93 | Congenital primary aphakia (HP:0007707) | 1.94557548 |
| 94 | Prolonged neonatal jaundice (HP:0006579) | 1.93967358 |
| 95 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.93895328 |
| 96 | Hypokinesia (HP:0002375) | 1.93846811 |
| 97 | Rough bone trabeculation (HP:0100670) | 1.93762106 |
| 98 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93701809 |
| 99 | Abnormality of B cell number (HP:0010975) | 1.92503734 |
| 100 | B lymphocytopenia (HP:0010976) | 1.92503734 |
| 101 | IgM deficiency (HP:0002850) | 1.92338804 |
| 102 | Encephalitis (HP:0002383) | 1.90769417 |
| 103 | Gait imbalance (HP:0002141) | 1.90624839 |
| 104 | Increased IgM level (HP:0003496) | 1.89416763 |
| 105 | Abnormality of T cells (HP:0002843) | 1.89265607 |
| 106 | Opisthotonus (HP:0002179) | 1.87991516 |
| 107 | True hermaphroditism (HP:0010459) | 1.87850892 |
| 108 | Retinal dysplasia (HP:0007973) | 1.87238265 |
| 109 | Progressive microcephaly (HP:0000253) | 1.84705570 |
| 110 | Albinism (HP:0001022) | 1.83165928 |
| 111 | Severe visual impairment (HP:0001141) | 1.83007997 |
| 112 | Granulocytopenia (HP:0001913) | 1.82609584 |
| 113 | Dry hair (HP:0011359) | 1.82571738 |
| 114 | Eczematoid dermatitis (HP:0000976) | 1.81268217 |
| 115 | Axonal loss (HP:0003447) | 1.80556250 |
| 116 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.80412212 |
| 117 | Prostate neoplasm (HP:0100787) | 1.80342359 |
| 118 | Type 2 muscle fiber atrophy (HP:0003554) | 1.78802841 |
| 119 | Hypertensive crisis (HP:0100735) | 1.78801679 |
| 120 | Severe combined immunodeficiency (HP:0004430) | 1.77537165 |
| 121 | Orchitis (HP:0100796) | 1.77396432 |
| 122 | Ketosis (HP:0001946) | 1.77034198 |
| 123 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.76492122 |
| 124 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.75105458 |
| 125 | Abnormality of macrophages (HP:0004311) | 1.74696422 |
| 126 | Pancreatic fibrosis (HP:0100732) | 1.72445892 |
| 127 | Hepatosplenomegaly (HP:0001433) | 1.67914232 |
| 128 | Increased serum pyruvate (HP:0003542) | 1.67607576 |
| 129 | Abnormality of glycolysis (HP:0004366) | 1.67607576 |
| 130 | Recurrent pneumonia (HP:0006532) | 1.67552256 |
| 131 | Neutropenia (HP:0001875) | 1.67339053 |
| 132 | Thrombocytosis (HP:0001894) | 1.65751566 |
| 133 | Abnormality of the columella (HP:0009929) | 1.63991680 |
| 134 | IgG deficiency (HP:0004315) | 1.63931049 |
| 135 | Recurrent fungal infections (HP:0002841) | 1.62433433 |
| 136 | Chromsome breakage (HP:0040012) | 1.62306235 |
| 137 | Pustule (HP:0200039) | 1.61820364 |
| 138 | Thyroiditis (HP:0100646) | 1.61792656 |
| 139 | Recurrent skin infections (HP:0001581) | 1.61502437 |
| 140 | Hypoproteinemia (HP:0003075) | 1.61436070 |
| 141 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.61382786 |
| 142 | Abnormality of the prostate (HP:0008775) | 1.61095578 |
| 143 | Premature graying of hair (HP:0002216) | 1.60921963 |
| 144 | Congenital sensorineural hearing impairment (HP:0008527) | 1.59730229 |
| 145 | Septo-optic dysplasia (HP:0100842) | 1.58817980 |
| 146 | Pancytopenia (HP:0001876) | 1.58454071 |
| 147 | Abnormality of the preputium (HP:0100587) | 1.58316898 |
| 148 | Renal tubular dysfunction (HP:0000124) | 1.57607713 |
| 149 | Abnormality of the axillary hair (HP:0100134) | 1.56005666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.02587802 |
| 2 | STK16 | 3.66041227 |
| 3 | NME2 | 3.28607904 |
| 4 | BCKDK | 2.66580554 |
| 5 | NME1 | 2.58136315 |
| 6 | CASK | 2.53832139 |
| 7 | BLK | 2.42454801 |
| 8 | MAP3K12 | 2.14792923 |
| 9 | TNIK | 2.13683166 |
| 10 | PIM2 | 2.12284751 |
| 11 | PBK | 2.05355574 |
| 12 | VRK1 | 2.04701755 |
| 13 | KDR | 1.98546939 |
| 14 | BUB1 | 1.98505265 |
| 15 | MST4 | 1.95025234 |
| 16 | TXK | 1.88417492 |
| 17 | IRAK4 | 1.87880498 |
| 18 | BMPR1B | 1.86564545 |
| 19 | MAPKAPK3 | 1.84304544 |
| 20 | MAPKAPK5 | 1.80825482 |
| 21 | ERN1 | 1.70210543 |
| 22 | MAP3K11 | 1.69874452 |
| 23 | EIF2AK3 | 1.65104720 |
| 24 | SIK3 | 1.65060442 |
| 25 | TLK1 | 1.64974972 |
| 26 | MARK3 | 1.59078311 |
| 27 | MAP3K3 | 1.58579378 |
| 28 | EIF2AK1 | 1.57265872 |
| 29 | CDK8 | 1.56254427 |
| 30 | ABL2 | 1.55217315 |
| 31 | MAP4K2 | 1.54792307 |
| 32 | BMPR2 | 1.51385046 |
| 33 | TAOK2 | 1.51204485 |
| 34 | CDK19 | 1.49502110 |
| 35 | PINK1 | 1.49275855 |
| 36 | GRK6 | 1.45936768 |
| 37 | KIT | 1.40256615 |
| 38 | TEC | 1.39597586 |
| 39 | MUSK | 1.37898664 |
| 40 | YES1 | 1.37672124 |
| 41 | CLK1 | 1.36323788 |
| 42 | PRPF4B | 1.34382365 |
| 43 | ADRBK2 | 1.33888508 |
| 44 | MAP3K14 | 1.28647628 |
| 45 | DAPK1 | 1.21657712 |
| 46 | GRK7 | 1.21498950 |
| 47 | MKNK1 | 1.19236151 |
| 48 | RIPK4 | 1.16913835 |
| 49 | SYK | 1.15085134 |
| 50 | LIMK1 | 1.12063622 |
| 51 | TAOK3 | 1.11618893 |
| 52 | ARAF | 1.11148959 |
| 53 | IRAK3 | 1.10719210 |
| 54 | TYK2 | 1.10455995 |
| 55 | DAPK3 | 1.10039926 |
| 56 | PRKCI | 1.09420392 |
| 57 | BRAF | 1.09327766 |
| 58 | JAK3 | 1.07880351 |
| 59 | DYRK2 | 1.07230775 |
| 60 | BTK | 1.07014150 |
| 61 | TAOK1 | 1.05368664 |
| 62 | MAP4K1 | 1.02684788 |
| 63 | CCNB1 | 1.01848251 |
| 64 | TBK1 | 1.01160093 |
| 65 | CSNK1G3 | 1.01083518 |
| 66 | MAP2K3 | 1.00704545 |
| 67 | SMG1 | 1.00564928 |
| 68 | EIF2AK2 | 0.97892263 |
| 69 | TESK2 | 0.95521479 |
| 70 | BCR | 0.93907387 |
| 71 | LYN | 0.92090802 |
| 72 | ERBB3 | 0.91654637 |
| 73 | MST1R | 0.90165165 |
| 74 | IKBKE | 0.89441148 |
| 75 | SCYL2 | 0.87944924 |
| 76 | MAP2K7 | 0.87881753 |
| 77 | OXSR1 | 0.87460097 |
| 78 | IKBKB | 0.85384160 |
| 79 | GRK5 | 0.83236561 |
| 80 | TIE1 | 0.82373378 |
| 81 | PIK3CA | 0.80170313 |
| 82 | LRRK2 | 0.79956867 |
| 83 | TGFBR1 | 0.79322869 |
| 84 | TAF1 | 0.78448770 |
| 85 | ZAP70 | 0.77558308 |
| 86 | MYLK | 0.76689021 |
| 87 | STK39 | 0.76392415 |
| 88 | MKNK2 | 0.75819060 |
| 89 | CDK3 | 0.74758634 |
| 90 | MAPK13 | 0.73678842 |
| 91 | GRK1 | 0.69487897 |
| 92 | PLK4 | 0.68999398 |
| 93 | ZAK | 0.68201942 |
| 94 | RPS6KA5 | 0.68136064 |
| 95 | TSSK6 | 0.66860538 |
| 96 | FES | 0.63315240 |
| 97 | PKN1 | 0.62612912 |
| 98 | LCK | 0.62596608 |
| 99 | CSNK1A1L | 0.61960275 |
| 100 | CSF1R | 0.61213189 |
| 101 | CSNK1G1 | 0.60076678 |
| 102 | ILK | 0.59799044 |
| 103 | MAP2K6 | 0.58172414 |
| 104 | IRAK1 | 0.56958025 |
| 105 | TESK1 | 0.55860779 |
| 106 | TRPM7 | 0.54999083 |
| 107 | IRAK2 | 0.54930935 |
| 108 | WEE1 | 0.54536568 |
| 109 | MAP3K5 | 0.53141528 |
| 110 | NUAK1 | 0.52399042 |
| 111 | TNK2 | 0.51395644 |
| 112 | CAMK2B | 0.50620151 |
| 113 | MATK | 0.50240997 |
| 114 | PRKCD | 0.48327758 |
| 115 | AURKA | 0.48255468 |
| 116 | DYRK3 | 0.47786959 |
| 117 | MAP2K2 | 0.45693070 |
| 118 | PRKCQ | 0.44996571 |
| 119 | PIM1 | 0.41967511 |
| 120 | CSNK2A1 | 0.41438283 |
| 121 | FGR | 0.41424211 |
| 122 | SRPK1 | 0.40465600 |
| 123 | NLK | 0.40335040 |
| 124 | CAMK2D | 0.40266393 |
| 125 | PAK1 | 0.40245890 |
| 126 | CAMKK2 | 0.40220980 |
| 127 | NEK1 | 0.39982103 |
| 128 | PASK | 0.39640979 |
| 129 | PAK4 | 0.39600631 |
| 130 | ACVR1B | 0.39596933 |
| 131 | MAP3K1 | 0.39373913 |
| 132 | ADRBK1 | 0.39207648 |
| 133 | STK24 | 0.39059401 |
| 134 | CSNK1G2 | 0.38293204 |
| 135 | MAP3K8 | 0.35672766 |
| 136 | UHMK1 | 0.35666792 |
| 137 | FLT3 | 0.35651625 |
| 138 | STK10 | 0.35648851 |
| 139 | RPS6KA6 | 0.35536131 |
| 140 | CSK | 0.35463154 |
| 141 | CDK9 | 0.31197904 |
| 142 | ITK | 0.31046860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.04106964 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.69442304 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.53300342 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.31984373 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.03575728 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.81077605 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.32561161 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.31616764 |
| 9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.24668457 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 2.12574508 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.00181792 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 1.95194623 |
| 13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.86186471 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.78867431 |
| 15 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.71535711 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 1.68173731 |
| 17 | Sulfur relay system_Homo sapiens_hsa04122 | 1.59555454 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.59175870 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.48375631 |
| 20 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.47059188 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.44548318 |
| 22 | Spliceosome_Homo sapiens_hsa03040 | 1.41657672 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33729761 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.33209404 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31403566 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28415690 |
| 27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.19579530 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.16410564 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.13821007 |
| 30 | Purine metabolism_Homo sapiens_hsa00230 | 1.12325097 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12250934 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.11681254 |
| 33 | Allograft rejection_Homo sapiens_hsa05330 | 1.08526364 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.07127118 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06892357 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06847886 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.02668394 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99214807 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98739998 |
| 40 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97936691 |
| 41 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.95593156 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93889978 |
| 43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93095666 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92968789 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91565124 |
| 46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91425661 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90496613 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89275544 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88105138 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87379845 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.87217314 |
| 52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.84962026 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84503385 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84205110 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80725428 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78119273 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 0.76083529 |
| 58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.75862181 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75583537 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74363008 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.72474018 |
| 62 | RNA degradation_Homo sapiens_hsa03018 | 0.71959249 |
| 63 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.71942045 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71824532 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.71041865 |
| 66 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71021565 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71009106 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.70009400 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.69555986 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69548966 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69398996 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69283019 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69126018 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69012671 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67856125 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67215904 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.66899337 |
| 78 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66257226 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.66146430 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65047735 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.64783271 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.64318140 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63938271 |
| 84 | Tuberculosis_Homo sapiens_hsa05152 | 0.63096932 |
| 85 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61748136 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.61083540 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60439853 |
| 88 | Measles_Homo sapiens_hsa05162 | 0.59536584 |
| 89 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.59106180 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58978465 |
| 91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58222737 |
| 92 | Phototransduction_Homo sapiens_hsa04744 | 0.57780340 |
| 93 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57481918 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57446038 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57186130 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56448177 |
| 97 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55773282 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.54257093 |
| 99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54227367 |
| 100 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53715663 |
| 101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.52834525 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52590761 |
| 103 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52161090 |
| 104 | Malaria_Homo sapiens_hsa05144 | 0.51491650 |
| 105 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.49979299 |
| 106 | RNA transport_Homo sapiens_hsa03013 | 0.49785197 |
| 107 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49504340 |
| 108 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.48667389 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48132539 |
| 110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45720706 |
| 111 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44431781 |
| 112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.42308231 |
| 113 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.41822163 |
| 114 | Alcoholism_Homo sapiens_hsa05034 | 0.40097945 |
| 115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40080288 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38624329 |
| 117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37988688 |
| 118 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.34601314 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.32771508 |
| 120 | Influenza A_Homo sapiens_hsa05164 | 0.31914083 |
| 121 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.31702129 |
| 122 | Cell cycle_Homo sapiens_hsa04110 | 0.31660753 |
| 123 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31550364 |
| 124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30245768 |
| 125 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.30223799 |
| 126 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.28347872 |
| 127 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27862337 |
| 128 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27623157 |
| 129 | Nicotine addiction_Homo sapiens_hsa05033 | 0.27367475 |
| 130 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.26136201 |
| 131 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26109781 |

